Cysteine cathepsin non-inhibitory binding partners: Modulating intracellular trafficking and function

Biological Chemistry

Volumn 388, Issue 11, 2007, Pages 1131-1140

  Victor, Bernadette C ^a   Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cathepsin B; Cysteine cathepsin; Glycosaminoglycan

Indexed keywords

BINDING PROTEIN; CATHEPSIN; CYSTEINE; GLYCOSAMINOGLYCAN;

ANGIOGENESIS; CANCER INVASION; CELL FUNCTION; CELL MIGRATION; CELL SURFACE; CONFERENCE PAPER; GENE OVEREXPRESSION; HUMAN; LYSOSOME; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TUMOR GROWTH;

CATHEPSINS; CYSTEINE; GLYCOSAMINOGLYCANS; LIGANDS; LYSOSOMES; PROTEIN TRANSPORT;

EID: 35848947186     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.150     Document Type: Conference Paper

References (127)

1. Adachi, W., Kawamoto, S., Ohno, I., Nishida, K., Kinoshita, S., Matsubara, K., and Okubo, K. (1998). Isolation and characterization of human cathepsin V: a major proteinase in corneal epithelium. Invest. Ophthalmol. Vis. Sci. 39, 1789-1796.
2. Almeida, P.C., Nantes, I.L., Rizzi, C.C., Judice, W.A., Chagas, J.R., Juliano, L., Nader, H.B., and Tersariol, I.L. (1999). Cysteine proteinase activity regulation. A possible role of heparin and heparin-like glycosaminoglycans. J. Biol. Chem. 274, 30433-30438.
3. Almeida, P.C., Nantes, I.L., Chagas, J.R., Rizzi, C.C., Faljoni-Alario, A., Carmona, E., Juliano, L., Nader, H.B., and Tersariol, I.L. (2001). Cathepsin B activity regulation. Heparin-like glycosaminoglycans protect human cathepsin B from alkaline pH-induced inactivation. J. Biol. Chem. 276, 944-951.
4. Andrews, N.W. (2000). Regulated secretion of conventional lysosomes. Trends Cell Biol. 10, 316-321.
5. Appenzeller, C., Andersson, H., Kappeler, F., and Hauri, H.P. (1999). The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat. Cell Biol. 1, 330-334.
6. Appenzeller-Herzog, C., Roche, A.C., Nufer, O., and Hauri, H.P. (2004). pH-induced conversion of the transport lectin ERGIC-53 triggers glycoprotein release. J. Biol. Chem. 279, 12943-12950.
7. Appenzeller-Herzog, C., Nyfeler, B., Burkhard, P., Santamaria, I., Lopez-Otin, C., and Hauri, H.P. (2005). Carbohydrate- and conformation-dependent cargo capture for ER-exit. Mol. Biol. Cell 16, 1258-1267.
8. + T cells that facilitate tumor development. J. Exp. Med. 204, 1037-1047.
9. Bafetti, L.M., Young, T.N., Itoh, Y., and Stack, M.S. (1998). Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem. 273, 143-149.
10. Benya, R.V., Matkowskyj, K.A., Danilkovich, A., and Hecht, G. (1998). Galanin causes Cl- secretion in the human colon. Potential significance of inflammation-associated NF-κB activation on galanin-1 receptor expression and function. Ann. NY Acad. Sci. 863, 64-77.
11. Berger, A., Santic, R., Hauser-Kronberger, C., Schilling, F.H., Kogner, P., Ratschek, M., Gamper, A., Jones, N., Sperl, W., and Kofler, B. (2005). Galanin and galanin receptors in human cancers. Neuropeptides 39, 353-359.
12. Bissell, M.J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
13. Borinstein, S.C., Hyatt, M.A., Sykes, V.W., Straub, R.E., Lipkowitz, S., Boulter, J., and Bogler, O. (2000). SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins. Cell. Signal. 12, 769-779.
14. Brix, K., Lemansky, P., and Herzog, V. (1996). Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 137, 1963-1974.
15. Buchner, D.A. and Meisler, M.H. (2003). TSRC1, a widely expressed gene containing seven thrombospondin type I repeats. Gene 307, 23-30.
16. Buth, H., Wolters, B., Hartwig, B., Meier-Bornheim, R., Veith, H., Hansen, M., Sommerhoff, C.P., Schaschke, N., Machleidt, W., Fusenig, N.E., et al. (2004). HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. Eur. J. Cell Biol. 83, 781-795.
17. Campo, E., Munoz, J., Miquel, R., Palacin, A., Cardesa, A., Sloane, B.F., and Emmert-Buck, M.R. (1994). Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am. J. Pathol. 145, 301-309.
18. Castiglioni, T., Merino, M.J., Elsner, B., Lah, T.T., Sloane, B.F., and Emmert-Buck, M.R. (1994). Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum. Pathol. 25, 857-862.
19. Caughey, G.H. (2002). New developments in the genetics and activation of mast cell proteases. Mol. Immunol. 38, 1353-1357.
20. Cavallo-Medved, D. and Sloane, B.F. (2003). Cell-surface cathepsin B: understanding its functional significance. Curr. Top. Dev. Biol. 54, 313-341.
21. Cavallo-Medved, D., Dosescu, J., Linebaugh, B.E., Sameni, M., Rudy, D., and Sloane, B.F. (2003). Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. Neoplasia 5, 507-519.
22. Chapman, H.A., Riese, R.J., and Shi, G.P. (1997). Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59, 63-88.
23. De Stefanis, D., Demoz, M., Dragonetti, A., Houri, J.J., Ogier-Denis, E., Codogno, P., Baccino, F.M., and Isidoro, C. (1997). Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res. 289, 109-117.
24. Demirov, D., Sarafian, V., Kremensky, I., and Ganev, V. (1999). Evidence for protein splicing in the endoplasmic reticulum-Golgi intermediate compartment. Biochim. Biophys. Acta 1448, 507-511.
25. Devanathan, G., Turnbull, J.L., Ziomek, E., Purisima, E.O., Menard, R., and Sulea, T. (2005). Carboxy-monopeptidase substrate specificity of human cathepsin X. Biochem. Biophys. Res. Commun. 329, 445-452.
26. Domoto, T., Miyama, Y., Suzuki, H., Teratani, T., Arai, K., Sugiyama, T., Takayama, T., Mugiya, S., Ozono, S., and Nozawa, R. (2007). Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci. 98, 77-82.
27. Drake, F.H., Dodds, R.A., James, I.E., Connor, J.R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., et al. (1996). Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271, 12511-12516.
28. El-Salhy, M. and Dennerqvist, V. (2004). Effects of triple therapy with octreotide, galanin and serotonin on liver metastasis of human colon cancer in xenografts. Oncol. Rep. 11, 1177-1182.
29. Emmert-Buck, M.R., Roth, M.J., Zhuang, Z., Campo, E., Rozhin, J., Sloane, B.F., Liotta, L.A., and Stetler-Stevenson, W.G. (1994). Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 145, 1285-1290.
30. Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M., and Jaattela, M. (2001). Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1010.
31. Fong, D., Calhoun, D.H., Hsieh, W.T., Lee, B., and Wells, R.D. (1986). Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. Proc. Natl. Acad. Sci. USA 83, 2909-2913.
32. Fong, D., Chan, M.M., Hsieh, W.T., Menninger, J.C., and Ward, D.C. (1992). Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8. Hum. Genet. 89, 10-12.
33. Fries, E. and Blom, A.M. (2000). Bikunin - not just a plasma proteinase inhibitor. Int. J. Biochem. Cell. Biol. 32, 125-137.
34. Frlan, R. and Gobec, S. (2006). Inhibitors of cathepsin B. Curr. Med. Chem. 13, 2309-2327.
35. Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F.H., McQueney, M.S., Foged, N.T., Delmas, P.D., and Delaisse, J.M. (1998). The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273, 32347-32352.
36. Gentry, H.R., Singer, A.U., Betts, L., Yang, C., Ferrara, J.D., Sondek, J., and Parise, L.V. (2005). Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins. J. Biol. Chem. 280, 8407-8415.
37. Gillies, R.J., Raghunand, N., Karczmar, G.S., and Bhujwalla, Z.M. (2002). MRI of the tumor microenvironment. J. Magn. Reson. Imaging 16, 430-450.
38. Gocheva, V. and Joyce, J.A. (2007). Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6, 60-64.
39. Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., and Joyce, J.A. (2006). Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556.
40. Gondi, C.S., Lakka, S.S., Dinh, D.H., Olivero, W.C., Gujrati, M., and Rao, J.S. (2004a). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 23, 8486-8496.
41. Gondi, C.S., Lakka, S.S., Yanamandra, N., Olivero, W.C., Dinh, D.H., Gujrati, M., Tung, C.H., Weissleder, R., and Rao, J.S. (2004b). Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res. 64, 4069-4077.
42. Guicciardi, M.E., Deussing, J., Miyoshi, H., Bronk, S.F., Svingen, P.A., Peters, C., Kaufmann, S.H., and Gores, G.J. (2000). Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127-1137.
43. Guicciardi, M.E., Miyoshi, H., Bronk, S.F., and Gores, G.J. (2001). Cathepsin B knockout mice are resistant to tumor necrosis factor-α- mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159, 2045-2054.
44. Honn, K.V., Timar, J., Rozhin, J., Bazaz, R., Sameni, M., Ziegler, G., and Sloane, B.F. (1994). A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. 214, 120-130.
45. Ii, K., Hizawa, K., Kominami, E., Bando, Y., and Katunuma, N. (1985). Different immunolocalizations of cathepsins B, H, and L in the liver. J. Histochem. Cytochem. 33, 1173-1175.
46. Iishi, H., Tatsuta, M., Baba, M., Uehara, H., Yano, H., and Nakaizumi, A. (1995). Chemoprevention by galanin against colon carcinogenesis induced by azoxymethane in Wistar rats. Int. J. Cancer 61, 861-863.
47. Itin, C., Roche, A.C., Monsigny, M., and Hauri, H.P. (1996). ERGIC-53 is a functional mannose-selective and calcium-dependent human homologue of leguminous lectins. Mol. Biol. Cell 7, 483-493.
48. Jane, D.T., DaSilva, L., Koblinski, J., Horwitz, M., Sloane, B.F., and Dufresne, M.J. (2002). Evidence for the involvement of cathepsin B in skeletal myoblast differentiation. J. Cell. Biochem. 84, 520-531.
49. Jedeszko, C. and Sloane, B.F. (2004). Cysteine cathepsins in human cancer. Biol. Chem. 385, 1017-1027.
50. Kappeler, F., Klopfenstein, D.R., Foguet, M., Paccaud, J.P., and Hauri, H.P. (1997). The recycling of ERGIC-53 in the early secretory pathway. ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COPII. J. Biol. Chem. 272, 31801-31808.
51. Kassam, G., Manro, A., Braat, C.E., Louie, P., Fitzpatrick, S.L., and Waisman, D.M. (1997). Characterization of the heparin binding properties of annexin II tetramer. J. Biol. Chem. 272, 15093-15100.
52. Khan, K.M. and Falcone, D.J. (1997). Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J. Biol. Chem. 272, 8270-8275.
53. Klemencic, I., Carmona, A.K., Cezari, M.H., Juliano, M.A., Juliano, L., Guncar, G., Turk, D., Krizaj, I., Turk, V., and Turk, B. (2000). Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase. Eur. J. Biochem. 267, 5404-5412.
54. Klose, A., Wilbrand-Hennes, A., Zigrino, P., Weber, E., Krieg, T., Mauch, C., and Hunzelmann, N. (2006). Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int. J. Cancer 118, 2735-2743.
55. Kobayashi, H., Ohi, H., Sugimura, M., Shinohara, H., Fujii, T., and Terao, T. (1992). Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res. 52, 3610-3614.
56. Koblinski, J.E., Dosescu, J., Sameni, M., Moin, K., Clark, K., and Sloane, B.F. (2002). Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J. Biol. Chem. 277, 32220-32227.
57. Kocher, T., Schultz-Thater, E., Gudat, F., Schaefer, C., Casorati, G., Juretic, A., Willimann, T., Harder, F., Heberer, M., and Spagnoli, G.C. (1995). Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55, 2236-2239.
58. Kornfeld, S. (1986). Trafficking of lysosomal enzymes in normal and disease states. J. Clin. Invest. 77, 1-6.
59. Kornfeld, S. (1990). Lysosomal enzyme targeting. Biochem. Soc. Trans. 18, 367-374.
60. Krueger, S., Haeckel, C., Buehling, F., and Roessner, A. (1999). Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. 59, 6010-6014.
61. Lakka, S.S., Gondi, C.S., Yanamandra, N., Olivero, W.C., Dinh, D.H., Gujrati, M., and Rao, J.S. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23, 4681-4689.
62. Li, Z., Hou, W.S., and Bromme, D. (2000). Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39, 529-536.
63. Li, Z., Hou, W.S., Escalante-Torres, C.R., Gelb, B.D., and Bromme, D. (2002). Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J. Biol. Chem. 277, 28669-28676.
64. Li, Z., Yasuda, Y., Li, W., Bogyo, M., Katz, N., Gordon, R.E., Fields, G.B., and Bromme, D. (2004). Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J. Biol. Chem. 279, 5470-5479.
65. Linebaugh, B.E., Sameni, M., Day, N.A., Sloane, B.F., and Keppler, D. (1999). Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur. J. Biochem. 264, 100-109.
66. + T-lymphocytes. FEBS Lett. 405, 253-259.
67. Liu, J., Guo, Q., Chen, B., Yu, Y., Lu, H., and Li, Y.Y. (2006a). Cathepsin B and its interacting proteins, bikunin and TSRC1, correlate with TNF-induced apoptosis of ovarian cancer cells OV-90. FEBS Lett. 580, 245-250.
68. Liu, J.P., Liu, N.S., Yuan, H.Y., Guo, Q., Lu, H., and Li, Y.Y. (2006b). Human homologue of SETA binding protein 1 interacts with cathepsin B and participates in TNF-induced apoptosis in ovarian cancer cells. Mol. Cell. Biochem. 292, 189-195.
69. Ludwig, T., Munier-Lehmann, H., Bauer, U., Hollinshead, M., Ovitt, C., Lobel, P., and Hoflack, B. (1994). Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts. EMBO J. 13, 3430-3437.
70. Maciewicz, R.A., Wardale, R.J., Etherington, D.J., and Paraskeva, C. (1989). Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int. J. Cancer 43, 478-486.
71. Mai, J., Finley, R.L. Jr., Waisman, D.M., and Sloane, B.F. (2000). Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275, 12806-12812.
72. Martinez-Zaguilan, R., Seftor, E.A., Seftor, R.E., Chu, Y.W., Gillies, R.J., and Hendrix, M.J. (1996). Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 14, 176-186.
73. Mauch, C., Adelmann-Grill, B., Hatamochi, A., and Krieg, T. (1989). Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett. 250, 301-305.
74. McCormick, D. (1993). Secretion of cathepsin B by human gliomas in vitro. Neuropathol. Appl. Neurobiol. 19, 146-151.
75. Mohamed, M.M. and Sloane, B.F. (2006). Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775.
76. Mort, J.S. and Buttle, D.J. (1997). Cathepsin B. Int. J. Biochem. Cell Biol. 29, 715-720.
77. Nagler, D.K., Zhang, R., Tam, W., Sulea, T., Purisima, E.O., and Menard, R. (1999). Human cathepsin X: a cysteine protease with unique carboxypeptidase activity. Biochemistry 38, 12648-12654.
78. Nascimento, F.D., Rizzi, C.C., Nantes, I.L., Stefe, I., Turk, B., Carmona, A.K., Nader, H.B., Juliano, L., and Tersariol, I.L. (2005). Cathepsin X binds to cell surface heparan sulfate proteoglycans. Arch. Biochem. Biophys. 436, 323-332.
79. Navab, R., Mort, J.S., and Brodt, P. (1997). Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clin. Exp. Metastasis 15, 121-129.
80. Nishimura, S., Fujita, M., Terata, N., Tani, T., Kodama, M., and Itoh, K. (1997). Expression of MAGE genes in colorectal carcinomas. Nihon Rinsho Meneki Gakkai Kaishi 20, 95-101.
81. Nyfeler, B., Michnick, S.W., and Hauri, H.P. (2005). Capturing protein interactions in the secretory pathway of living cells. Proc. Natl. Acad. Sci. USA 102, 6350-6355.
82. Ondr, J.K. and Pham, C.T. (2004). Characterization of murine cathepsin W and its role in cell-mediated cytotoxicity. J. Biol. Chem. 279, 27525-27533.
83. Pham, C.T. and Ley, T.J. (1999). Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA 96, 8627-8632.
84. Podgorski, I. and Sloane, B.F. (2003). Cathepsin B and its role(s) in cancer progression. Biochem. Soc. Symp. 70, 263-276.
85. Poole, A.R., Tiltman, K.J., Recklies, A.D., and Stoker, T.A. (1978). Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 273, 545-547.
86. Premzl, A., Zavasnik-Bergant, V., Turk, V., and Kos, J. (2003). Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp. Cell Res. 283, 206-214.
87. Prieschl, E.E., Pendl, G.G., Harrer, N.E., and Baumruker, T. (1996). The murine homolog of TB2/DP1, a gene of the familial adenomatous polyposis (FAP) locus. Gene 169, 215-218.
88. Rawlings, N.D., Morton, F.R., and Barrett, A.J. (2006). MEROPS: the peptidase database. Nucleic Acids Res. 34, D270-D272.
89. Reinheckel, T., Deussing, J., Roth, W., and Peters, C. (2001). Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol. Chem. 382, 735-741.
90. Rempel, S.A., Rosenblum, M.L., Mikkelsen, T., Yan, P.S., Ellis, K.D., Golembieski, W.A., Sameni, M., Rozhin, J., Ziegler, G., and Sloane, B.F. (1994). Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54, 6027-6031.
91. Riese, R.J., Mitchell, R.N., Villadangos, J.A., Shi, G.P., Palmer, J.T., Karp, E.R., De Sanctis, G.T., Ploegh, H.L., and Chapman, H.A. (1998). Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101, 2351-2363.
92. 2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J. Cell Biol. 137, 93-104.
93. Roshy, S., Sloane, B.F., and Moin, K. (2003). Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22, 271-286.
94. Roth, W., Deussing, J., Botchkarev, V.A., Pauly-Evers, M., Saftig, P., Hafner, A., Schmidt, P., Schmahl, W., Scherer, J., Anton-Lamprecht, I., et al. (2000). Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J. 14, 2075-2086.
95. Rozhin, J., Sameni, M., Ziegler, G., and Sloane, B.F. (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525.
96. Rust, R., Visser, L., van der Leij, J., Harms, G., Blokzijl, T., Deloulme, J.C., van der Vlies, P., Kamps, W., Kok, K., Lim, M., et al. (2005). High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma. Br. J. Haematol. 131, 596-608.
97. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J.D., Schu, P., and von Figura, K. (1998). Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 95, 13453-13458.
98. Sameni, M., Elliott, E., Ziegler, G., Fortgens, P.H., Dennison, C., and Sloane, B.F. (1995). Cathepsin B and D are localized at the surface of human breast cancer cells. Pathol. Oncol. Res. 1, 43-53.
99. Sameni, M., Dosescu, J., Moin, K., and Sloane, B.F. (2003). Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Mol. Imaging 2, 159-175.
100. Santamaria, I., Velasco, G., Cazorla, M., Fueyo, A., Campo, E., and Lopez-Otin, C. (1998). Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 58, 1624-1630.
101. Shi, G.P., Bryant, R.A., Riese, R., Verhelst, S., Driessen, C., Li, Z., Bromme, D., Ploegh, H.L., and Chapman, H.A. (2000). Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191, 1177-1186.
102. Shi, G.P., Villadangos, J.A., Dranoff, G., Small, C., Gu, L., Haley, K.J., Riese, R., Ploegh, H.L., and Chapman, H.A. (1999). Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10, 197-206.
103. Sinha, A.A., Gleason, D.F., Deleon, O.F., Wilson, M.J., and Sloane, B.F. (1993). Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat. Rec. 235, 233-240.
104. Sinha, A.A., Wilson, M.J., Gleason, D.F., Reddy, P.K., Sameni, M., and Sloane, B.F. (1995). Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate 26, 171-178.
105. Sloane, B.F., Dunn, J.R., and Honn, K.V. (1981). Lysosomal cathepsin B: correlation with metastatic potential. Science 212, 1151-1153.
106. Sloane, B.F., Moin, K., Sameni, M., Tait, L.R., Rozhin, J., and Ziegler, G. (1994). Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J. Cell Sci. 107, 373-384.
107. Sloane, B.F., Rozhin, J., Johnson, K., Taylor, H., Crissman, J.D., and Honn, K.V. (1986). Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA 83, 2483-2487.
108. Sloane, B.F., Rozhin, J., Lah, T.T., Day, N.A., Buck, M., Ryan, R.E., Crissman, J.D., and Honn, K.V. (1988). Tumor cathepsin B and its endogenous inhibitors in metastasis. Adv. Exp. Med. Biol. 233, 259-268.
109. Sloane, B.F., Sameni, M., Podgorski, I., Cavallo-Medved, D., and Moin, K. (2006). Functional imaging of tumor proteolysis. Annu. Rev. Pharmacol. Toxicol. 46, 301-315.
110. Stypmann, J., Glaser, K., Roth, W., Tobin, D.J., Petermann, I., Matthias, R., Monnig, G., Haverkamp, W., Breithardt, G., Schmahl, W., et al. (2002). Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc. Natl. Acad. Sci. USA 99, 6234-6239.
111. Sukoh, N., Abe, S., Nakajima, I., Ogura, S., Isobe, H., Inoue, K., and Kawakami, Y. (1994). Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virchow's Arch. 424, 33-38.
112. Szpaderska, A.M. and Frankfater, A. (2001). An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61, 3493-3500.
113. Tahara, E. Jr., Tahara, H., Kanno, M., Naka, K., Takeda, Y., Matsuzaki, T., Yamazaki, R., Ishihara, H., Yasui, W., Barrett, J.C., et al. (2005). G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrialmediated apoptosis in gastric cancer cell line TMK-1 cell. Cancer Immunol. Immunother. 54, 729-740.
114. Tepel, C., Bromme, D., Herzog, V., and Brix, K. (2000). Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J. Cell Sci. 113, 4487-4498.
115. Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., and Kumegawa, M. (1994). Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269, 1106-1109.
116. Troen, B.R. (2004). The role of cathepsin K in normal bone resorption. Drug News Perspect. 17, 19-28.
117. Troen, B.R. (2006). The regulation of cathepsin K gene expression. Ann. NY Acad. Sci. 1068, 165-172.
118. Turk, V., Turk, B., and Turk, D. (2001). Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20, 4629-4633.
119. Vasiljeva, O., Papazoglou, A., Kruger, A., Brodoefel, H., Korovin, M., Deussing, J., Augustin, N., Nielsen, B.S., Almholt, K., Bogyo, M., et al. (2006). Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 66, 5242-5250.
120. Vasiljeva, O., Reinheckel, T., Peters, C., Turk, D., Turk, V., and Turk, B. (2007). Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 13, 385-401.
121. Visscher, D.W., Sloane, B.F., Sameni, M., Babiarz, J.W., Jacobson, J., and Crissman, J.D. (1994). Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. Mod. Pathol. 7, 76-81.
122. Vollenweider, F., Kappeler, F., Itin, C., and Hauri, H.P. (1998). Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J. Cell Biol. 142, 377-389.
123. Wang, B., Sun, J., Kitamoto, S., Yang, M., Grubb, A., Chapman, H.A., Kalluri, R., and Shi, G.P. (2006). Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J. Biol. Chem. 281, 6020-6029.
124. Watanabe, M., Higashi, T., Watanabe, A., Osawa, T., Sato, Y., Kimura, Y., Tominaga, S., Hashimoto, N., Yoshida, Y., Morimoto, S., et al. (1989). Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings. Biochem. Med. Metab. Biol. 42, 21-29.
125. Wex, T., Buhling, F., Wex, H., Gunther, D., Malfertheiner, P., Weber, E., and Bromme, D. (2001). Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum. J. Immunol. 167, 2172-2178.
126. Yasothornsrikul, S., Greenbaum, D., Medzihradszky, K.F., Toneff, T., Bundey, R., Miller, R., Schilling, B., Petermann, I., Dehnert, J., Logvinova, A., et al. (2003). Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc. Natl. Acad. Sci. USA 100, 9590-9595.
127. Yasuda, Y., Li, Z., Greenbaum, D., Bogyo, M., Weber, E., and Bromme, D. (2004). Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J. Biol. Chem. 279, 36761-36770.